Literature DB >> 27029580

Identification of the pXO1 plasmid in attenuated Bacillus anthracis vaccine strains.

Xudong Liang1, Huijuan Zhang1, Enmin Zhang1, Jianchun Wei1, Wei Li1, Bingxiang Wang2, Shulin Dong2, Jin Zhu3.   

Abstract

Anthrax toxins and capsule are the major virulence factors of Bacillus anthracis. They are encoded by genes located on the plasmids pXO1 and pXO2, respectively. The vaccine strain Pasteur II was produced from high temperature subcultures of B. anthracis, which resulted in virulence attenuation through the loss of the plasmid pXO1. However, it is unclear whether the high temperature culture completely abolishes the plasmid DNA or affects the replication of the plasmid pXO1. In this study, we tested 3 B. anthracis vaccine strains, including Pasteur II from France, Qiankefusiji II from Russia, and Rentian II from Japan, which were all generated from subcultures at high temperatures. Surprisingly, we detected the presence of pXO1 plasmid DNA using overlap PCR in all these vaccine strains. DNA sequencing analysis of overlap PCR products further confirmed the presence of pXO1. Moreover, the expression of the protective antigen (PA) encoded on pXO1 was determined by using SDS-PAGE and western blotting. In addition, we mimicked Pasteur's method and exposed the A16R vaccine strain, which lacks the pXO2 plasmid, to high temperature, and identified the pXO1 plasmid in the subcultures at high temperatures. This indicated that the high temperature treatment at 42.5°C was unable to eliminate pXO1 plasmid DNA from B. anthracis. Our results suggest that the attenuation of the Pasteur II vaccine strain is likely due to the impact of high temperature stress on plasmid replication, which in turn limits the copy number of pXO1. Our data provide new insights into the mechanisms of the remaining immunogenicity and toxicity of the vaccine strains.

Entities:  

Keywords:  attenuated; bacillus anthracis; pXO1 plasmid; vaccine strains

Mesh:

Substances:

Year:  2016        PMID: 27029580      PMCID: PMC5026784          DOI: 10.1080/21505594.2016.1164366

Source DB:  PubMed          Journal:  Virulence        ISSN: 2150-5594            Impact factor:   5.882


  19 in total

1.  Intranasal immunization with protective antigen of Bacillus anthracis induces a long-term immunological memory response.

Authors:  Sun-Je Woo; Seok-Seong Kang; Sung-Moo Park; Jae Seung Yang; Man Ki Song; Cheol-Heui Yun; Seung Hyun Han
Journal:  Mol Immunol       Date:  2015-08-14       Impact factor: 4.407

2.  Cross-talk to the genes for Bacillus anthracis capsule synthesis by atxA, the gene encoding the trans-activator of anthrax toxin synthesis.

Authors:  I Uchida; S Makino; T Sekizaki; N Terakado
Journal:  Mol Microbiol       Date:  1997-03       Impact factor: 3.501

3.  Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig.

Authors:  S F Little; G B Knudson
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

4.  Virulence and immunogenicity in experimental animals of Bacillus anthracis strains harbouring or lacking 110 MDa and 60 MDa plasmids.

Authors:  I Uchida; K Hashimoto; N Terakado
Journal:  J Gen Microbiol       Date:  1986-02

5.  Global effects of virulence gene regulators in a Bacillus anthracis strain with both virulence plasmids.

Authors:  Agathe Bourgogne; Melissa Drysdale; Susan G Hilsenbeck; Scott N Peterson; Theresa M Koehler
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

6.  A plasmid-encoded regulator couples the synthesis of toxins and surface structures in Bacillus anthracis.

Authors:  Tâm Mignot; Michèle Mock; Agnès Fouet
Journal:  Mol Microbiol       Date:  2003-02       Impact factor: 3.501

7.  Sequence and organization of pXO1, the large Bacillus anthracis plasmid harboring the anthrax toxin genes.

Authors:  R T Okinaka; K Cloud; O Hampton; A R Hoffmaster; K K Hill; P Keim; T M Koehler; G Lamke; S Kumano; J Mahillon; D Manter; Y Martinez; D Ricke; R Svensson; P J Jackson
Journal:  J Bacteriol       Date:  1999-10       Impact factor: 3.490

8.  BslA, a pXO1-encoded adhesin of Bacillus anthracis.

Authors:  Justin W Kern; Olaf Schneewind
Journal:  Mol Microbiol       Date:  2008-04       Impact factor: 3.501

9.  Noncanonical SMC protein in Mycobacterium smegmatis restricts maintenance of Mycobacterium fortuitum plasmids.

Authors:  Michael W Panas; Paras Jain; Hui Yang; Shimontini Mitra; Debasis Biswas; Alice Rebecca Wattam; Norman L Letvin; William R Jacobs
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-02       Impact factor: 11.205

10.  From genomics to chemical genomics: new developments in KEGG.

Authors:  Minoru Kanehisa; Susumu Goto; Masahiro Hattori; Kiyoko F Aoki-Kinoshita; Masumi Itoh; Shuichi Kawashima; Toshiaki Katayama; Michihiro Araki; Mika Hirakawa
Journal:  Nucleic Acids Res       Date:  2006-01-01       Impact factor: 16.971

View more
  8 in total

1.  Pasteur revisited: An unexpected finding in Bacillus anthracis vaccine strains.

Authors:  Peter Thorkildson; Haley L Kinney; David P AuCoin
Journal:  Virulence       Date:  2016-05-10       Impact factor: 5.882

2.  Development of a set of three real-time loop-mediated isothermal amplification (LAMP) assays for detection of Bacillus anthracis, the causative agent of anthrax.

Authors:  Swati Banger; Vijai Pal; N K Tripathi; A K Goel
Journal:  Folia Microbiol (Praha)       Date:  2021-04-09       Impact factor: 2.099

3.  A Single Nucleotide Polymorphism Is Involved in Regulation of Growth and Spore Formation of Bacillus anthracis Pasteur II Strain.

Authors:  Xudong Liang; Jin Zhu; Zhongzhi Zhao; Feng Zheng; Enmin Zhang; Jianchun Wei; Yon Ji; Yinduo Ji
Journal:  Front Cell Infect Microbiol       Date:  2017-06-28       Impact factor: 5.293

4.  The pag Gene of pXO1 Is Involved in Capsule Biosynthesis of Bacillus anthracis Pasteur II Strain.

Authors:  Xudong Liang; Jin Zhu; Zhongzhi Zhao; Feng Zheng; Huijuan Zhang; Jianchun Wei; Yon Ji; Yinduo Ji
Journal:  Front Cell Infect Microbiol       Date:  2017-05-26       Impact factor: 5.293

5.  Aerosolized Intratracheal Inoculation of Recombinant Protective Antigen (rPA) Vaccine Provides Protection Against Inhalational Anthrax in B10.D2-Hc0 Mice.

Authors:  Xiaolin Song; Wei Zhang; Lina Zhai; Jianshu Guo; Yue Zhao; Lili Zhang; Lingfei Hu; Xiaolu Xiong; Dongsheng Zhou; Meng Lv; Wenhui Yang
Journal:  Front Immunol       Date:  2022-01-26       Impact factor: 7.561

6.  Involvement of the pagR gene of pXO2 in anthrax pathogenesis.

Authors:  Xudong Liang; Enmin Zhang; Huijuan Zhang; Jianchun Wei; Wei Li; Jin Zhu; Bingxiang Wang; Shulin Dong
Journal:  Sci Rep       Date:  2016-07-01       Impact factor: 4.379

7.  Combination therapy of hTERTR and FAM96A for hepatocellular carcinoma through enhancing apoptosis sensitivity.

Authors:  Wan-Peng Wang; Hai-Ying Gao
Journal:  Exp Ther Med       Date:  2017-11-13       Impact factor: 2.447

8.  Using a Syrian (Golden) Hamster Biological Model for the Evaluation of Recombinant Anthrax Vaccines.

Authors:  Tatiana Kravchenko; Galina Titareva; Irina Bakhteeva; Tatiana Kombarova; Alexander Borzilov; Raisa Mironova; Kseniya Khlopova; Vitalii Timofeev
Journal:  Life (Basel)       Date:  2021-12-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.